Health Care Equipment & Services

Explore Evolent Health’s Q4 2025 earnings: $468.7 m revenue, 30 % growth, $151 m adjusted EBITDA, and a 2026 outlook with projected margin expansion and new high‑profile health‑plan partnerships.

Avanos Medical turns the corner: Q4 2025 shows a dramatic move from loss to modest profit, slashing debt and boosting margins while still chasing sustainable growth.

Discover Zentek Ltd.’s latest market update: volatile share prices, negative earnings yet promising nano‑material growth, and future‑focused investment insights.

Axogen Inc.

Theralase Technologies’ laser therapy shows promise, but its financials are shaky—watch the 2026 EUU congress for a potential game‑changer.

Teladoc Health’s stock plunge, negative earnings, and new exec hire show the firm’s struggle and potential reset in telemedicine’s competitive market.

Veeva Systems’ latest quarterly report shows a $182.57 share price and $30B market cap, yet high P/E and price‑to‑book ratios raise questions about its valuation and future growth.

PROCEPT BioRobotics Corp: 2026 stock outlook and financial challenges – a deep dive into its market volatility, negative earnings, and future prospects for investors.

Intuitive Surgical’s stock hits $499.53, backing a 169‑billion‑dollar healthcare tech giant whose earnings‑to‑price ratio of 62.5 signals strong, future‑growth potential for long‑term investors.

Explore Molina Healthcare’s decade‑long resilience: 128% ROI, Medicaid focus, cost‑control edge, and regulatory risks – a smart play for long‑term investors.